CMS pushed to set national policy on Aduhelm access
(By Nick Moran for Becker’s Hospital Review) The Alzheimer’s Association joins insurers as the latest to call for CMS to
Read More
Alzheimer’s/Dementia
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
(By Elisabeth Rosenthal for Kaiser Health News) The Food and Drug Administration’s approval in June of a drug purporting to
Read MoreDoctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
(By Judith Graham for Kaiser Health News) As physicians and health policy experts debate the merits of Aduhelm, the first
Read MorePaying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
(By Judith Graham for Kaiser Health News) If you could invest $56 billion each year in improving health care for
Read MoreMedicare could limit who gets new Alzheimer’s drug
(By Lauren Jensik for Becker’s Hospital Review) Medicare members could face barriers to accessing Biogen’s new Alzheimer’s drug, Aduhelm, due to
Read MoreWill Biogen’s new Alzheimer’s drug’s burden on Medicare be big, huge, or catastrophic?
(By Rachel Cohrs and J. Emory Parker for STAT) The Food and Drug Administration’s decision to grant wide-ranging approval to
Read MorePoint32Health challenges Aduhelm, threatens coverage for 1.1M members
(By Nick Moran for Becker’s Hospital Review) Point32Health may not cover Biogen’s new Alzheimer’s treatment, Aduhelm, for its commercial members unless
Read MoreA crucial, overlooked question on the new Alzheimer’s drug: When should patients stop taking it?
(By Megan Molteni for STAT) For families and physicians grappling with the historic approval this month of the controversial Alzheimer’s
Read MoreQ&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read More‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
(By Elizabeth Cooney for STAT) Their phones are ringing off the hook and their email inboxes are filling up with
Read More